FJERZA, RAJMONDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 752
EU - Europa 615
AS - Asia 105
OC - Oceania 3
AF - Africa 1
Totale 1.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 751
PL - Polonia 264
RU - Federazione Russa 166
IT - Italia 61
IE - Irlanda 32
CN - Cina 30
SE - Svezia 29
SG - Singapore 29
HK - Hong Kong 27
FI - Finlandia 14
DE - Germania 13
CH - Svizzera 10
GB - Regno Unito 8
FR - Francia 7
JO - Giordania 7
UA - Ucraina 7
ID - Indonesia 4
VN - Vietnam 4
AU - Australia 3
IN - India 3
BE - Belgio 2
ES - Italia 2
CA - Canada 1
KR - Corea 1
SC - Seychelles 1
Totale 1.476
Salva come PNG Salva come JPEG
Città #
Warsaw 264
Santa Clara 223
Fairfield 88
Chandler 58
Woodbridge 52
Ashburn 50
Seattle 34
Dublin 32
Wilmington 25
Houston 23
Ann Arbor 22
Cambridge 22
Singapore 22
Hong Kong 20
Altamura 16
Princeton 15
Lawrence 14
Bern 10
Trieste 10
Beijing 9
Florence 9
Bremen 8
Buffalo 8
Campi Bisenzio 8
Shanghai 8
Kent 7
Boston 6
Helsinki 6
Jacksonville 6
Jakarta 4
Medford 4
Fiesole 3
Los Angeles 3
Melbourne 3
Mumbai 3
Barcelona 2
Brussels 2
Dong Ket 2
New York 2
Norwalk 2
Padova 2
Phoenix 2
Redwood City 2
West Jordan 2
Yubileyny 2
Anaheim 1
Azzano San Paolo 1
Boardman 1
Caronno Pertusella 1
Dearborn 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Guangzhou 1
Moscow 1
Munich 1
Novomoskovsk 1
Salerno 1
Seoul 1
Shenyang 1
Shenzhen 1
Toronto 1
Verona 1
Villa Minozzo 1
Wandsworth 1
Wuhu 1
Totale 1.136
Salva come PNG Salva come JPEG
Nome #
Patients with ≥ 20 × 10(9)/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience. 289
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: An observational, hypothesis-generating study 248
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 167
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 147
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 140
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 137
Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group 105
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 88
Two case of Hermansky-Pudlak Syndrome associated with novel mutations in HPS3 and HPS6 genes. 79
Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience 78
Is pharmacological thromboprophylaxis necessary in persons with haemophilia undergoing major orthopaedic surgery? 19
Totale 1.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020123 0 0 0 0 0 0 25 33 24 16 20 5
2020/2021127 10 15 2 21 8 8 6 8 12 15 15 7
2021/202259 2 8 1 3 1 3 1 5 1 5 11 18
2022/2023225 19 51 14 22 11 30 20 15 28 3 2 10
2023/202497 4 7 10 13 3 12 1 26 1 8 10 2
2024/2025486 23 58 33 99 170 103 0 0 0 0 0 0
Totale 1.497